Electrolyte abnormalities with zoledronic acid therapy - Reply

被引：0
|
作者：
Rosen, LS [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
来源：
CANCER JOURNAL | 2002年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：348 / 349
页数：2
相关论文
共 50 条
  • [1] Severe Electrolyte Abnormalities after Zoledronic Acid Treatment for Osteoporosis
    Le, Nina
    Rosen, Stephen G.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [2] High Incidence of electrolyte abnormalities despite low first dose of Zoledronic acid
    Grover, Monica
    Bachrach, Laura
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 130 - 130
  • [3] Zoledronic acidSevere electrolyte abnormalities: case report
    Reactions Weekly, 2016, 1613 (1) : 274 - 274
  • [4] Breast-Cancer Adjuvant Therapy with Zoledronic Acid REPLY
    Coleman, Robert E.
    Marshall, Helen
    Bell, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02): : 189 - 189
  • [5] Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer REPLY
    Gnant, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2369 - 2370
  • [6] Zoledronic acid for preventing fractures - Reply
    Ringe, J. D.
    INTERNIST, 2008, 49 (08): : 1002 - 1002
  • [7] Reply to Bone morphogenetic proteins and zoledronic acid
    Bertagna, X.
    Boudou-Rouquette, P.
    Alexandre, J.
    Soubtane, O.
    Goldwasser, F.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 2019 - 2019
  • [8] Yearly zoledronic acid in postmenopausal osteoporosis - Reply
    Black, Dennis
    Eriksen, Erik
    Sellmeyer, Deborah
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (07): : 714 - 715
  • [9] Zoledronic Acid Dosing Interval for Metastatic Cancer Reply
    Himelstein, Andrew L.
    Loprinzi, Charles L.
    Shapiro, Charles L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (14): : 1478 - 1478
  • [10] Fracture Risk and Zoledronic Acid in Men with Osteoporosis Reply
    Boonen, Steven
    Orwoll, Eric
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (09): : 873 - 873
12345